

Cover Story
Free
By Matthew Bin Han Ong
The Blue Ribbon Panel—a group of experts selected to identify scientific opportunities for the National Cancer Moonshot Initiative—has submitted 10 recommendations to the National Cancer Advisory Board.
By Laura Brawley
In Brief


Drugs & Targets


Trending Stories
- With five-year cancer survival at an all-time high, does this mean people are living longer?
- House passes three-year extension of ACA subsidies with bipartisan support
- When “safe and effective” is not “reasonable and necessary”
We can curb excessive drug dosing and improve the quality of cancer care - Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
- The Mark Foundation names 2026 Emerging Leader Award recipients
- A radiation oncologist’s perspective: Why we need to accelerate early detection strategies for lung cancers













